You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ATRACURIUM BESYLATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Atracurium Besylate, and when can generic versions of Atracurium Besylate launch?

Atracurium Besylate is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Eugia Pharma, Hikma, Hospira, Hospira Inc, Meitheal, Norvium Bioscience, Teva Parenteral, Watson Pharms Teva, and Watson Labs Inc. and is included in twenty-two NDAs.

The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Atracurium Besylate

A generic version of ATRACURIUM BESYLATE was approved as atracurium besylate by HIKMA on July 18th, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ATRACURIUM BESYLATE?
  • What are the global sales for ATRACURIUM BESYLATE?
  • What is Average Wholesale Price for ATRACURIUM BESYLATE?
Drug patent expirations by year for ATRACURIUM BESYLATE
Recent Clinical Trials for ATRACURIUM BESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityN/A
Theodor Bilharz Research InstitutePhase 4
Cairo UniversityPhase 4

See all ATRACURIUM BESYLATE clinical trials

Pharmacology for ATRACURIUM BESYLATE
Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE

US Patents and Regulatory Information for ATRACURIUM BESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074824-001 Sep 30, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074741-001 Mar 28, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira Inc ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 090761-001 Oct 18, 2012 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074901-001 Jul 18, 1997 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074825-001 Sep 30, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Meitheal ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 091488-001 Feb 17, 2012 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.